ASHLEY OWENS: Open Payments
NPI 1033663265 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,626 in 115 payments from 17 companies in 2025. Trend: 2023 $1,766 · 2024 $2,294 · 2025 $2,626
Food & beverage: $2,464Education: $162
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $516 |
| UCB, Inc. | 13 | $365 |
| Novartis Pharmaceuticals Corporation | 10 | $268 |
| Janssen Biotech, Inc. | 14 | $266 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $236 |
| Amgen Inc. | 8 | $177 |
| Lilly USA, LLC | 11 | $165 |
| GENZYME CORPORATION | 5 | $154 |
| LEO Pharma Inc. | 7 | $139 |
| Regeneron Healthcare Solutions, Inc. | 3 | $94 |
Products named: Bimzelx, RINVOQ, TREMFYA, DUPIXENT, SKYRIZI, COSENTYX, OTEZLA, TALTZ.
Industry payments across NV — which companies pay providers there.
